http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#head http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#assertion http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#provenance http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#publicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#assertion http://bio2rdf.org/drugbank:DB00541 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00541_DB01149 http://bio2rdf.org/drugbank:DB01149 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00541_DB01149 http://bio2rdf.org/drugbank_resource:DB00541_DB01149 http://purl.org/dc/terms/identifier drugbank_resource:DB00541_DB01149 http://bio2rdf.org/drugbank_resource:DB00541_DB01149 http://purl.org/dc/terms/title DDI between Vincristine and Nefazodone - Nefazodone, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Nefazodone is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00541_DB01149 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00541_DB01149 http://www.w3.org/2000/01/rdf-schema#label DDI between Vincristine and Nefazodone - Nefazodone, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Nefazodone is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB01149] http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#provenance http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#publicationInfo http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#signature.MCwCFGzgDe1JW6ng http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#signature.MCwCFGzgDe1JW6ng http://purl.org/nanopub/x/hasSignature MCwCFGzgDe1JW6ngjPIqGWvtpiUdn/lzAhQScEsHYd/NycCyBxDZSgV4kE165A== http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#signature.MCwCFGzgDe1JW6ng http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM http://purl.org/dc/terms/created 2018-03-30T11:13:16.449+02:00 http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM#signature.MCwCFGzgDe1JW6ng http://bio2rdf.org/drugbank_resource:DB00541_DB01149_nanopub.RAVE7l8U2eRnenrBFAbGgGo438ej7y-ce6alivIndIiVM http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234